Home NDC 63629-6404-1 Triamterene and Hydrochlorothiazide
Product NDC 63629-6404
Requested package NDC 63629-6404-1
11-digit product format 636296404
Labeler code 63629
Product ID 63629-6404_f20127b7-9a3a-46ed-b64e-a8ae880ae9ca
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Triamterene and Hydrochlorothiazide
Dosage form TABLET
Route ORAL
Labeler Bryant Ranch Prepack
Application NDA019129
Marketing category NDA
Marketing start 1996-09-16
Marketing end 0000-00-00
Substance TRIAMTERENE; HYDROCHLOROTHIAZIDE
Active strength 75 mg/1; mg/1
Pharmacologic classes Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [CS],Decreased Renal K+ Excretion [PE],Increased Diuresis [PE],Potassium-sparing Diuretic [EPC]
NDC exclude flag No
Listing certified through 2021-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 13 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Code, Status table Captured / source date Code Status Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 D Discontinued by firm d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 D Discontinued by firm f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 D Discontinued by firm 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 D Discontinued by firm a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 D Discontinued by firm cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 D Discontinued by firm cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 D Discontinued by firm 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 D Discontinued by firm ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 D Discontinued by firm 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 D Discontinued by firm ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 D Discontinued by firm 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 D Discontinued by firm 557ba5c1ecfa…9c80585c8c6e…2020-06-10 20:45 UTC · source 2020-06-10 I Inactivated by FDA 9bebd1f3094a…5416666fcb17…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 43 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N019129-001 MAXZIDE HYDROCHLOROTHIAZIDE; TRIAMTERENE 50MG;75MG TABLET / ORAL AB RLD, RS 1984-10-22 N019129-003 MAXZIDE-25 HYDROCHLOROTHIAZIDE; TRIAMTERENE 25MG;37.5MG TABLET / ORAL AB RLD 1988-05-13
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 2 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 3 · 86 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-09-14 22:38:34 2026-08 N019129-001 MAXZIDE 50MG;75MG TABLET / ORAL AB RLD, RS 1984-10-22 84e616aacf4f…2026-09-14 22:38:34 2026-08 N019129-003 MAXZIDE-25 25MG;37.5MG TABLET / ORAL AB RLD 1988-05-13 84e616aacf4f…2026-08-18 06:07:40 2026-07 N019129-001 MAXZIDE 50MG;75MG TABLET / ORAL AB RLD, RS 1984-10-22 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N019129-003 MAXZIDE-25 25MG;37.5MG TABLET / ORAL AB RLD 1988-05-13 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N019129-001 MAXZIDE 50MG;75MG TABLET / ORAL AB RLD, RS 1984-10-22 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N019129-003 MAXZIDE-25 25MG;37.5MG TABLET / ORAL AB RLD 1988-05-13 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N019129-001 MAXZIDE 50MG;75MG TABLET / ORAL AB RLD, RS 1984-10-22 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N019129-003 MAXZIDE-25 25MG;37.5MG TABLET / ORAL AB RLD 1988-05-13 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N019129-001 MAXZIDE 50MG;75MG TABLET / ORAL AB RLD, RS 1984-10-22 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N019129-003 MAXZIDE-25 25MG;37.5MG TABLET / ORAL AB RLD 1988-05-13 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N019129-001 MAXZIDE 50MG;75MG TABLET / ORAL AB RLD, RS 1984-10-22 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N019129-003 MAXZIDE-25 25MG;37.5MG TABLET / ORAL AB RLD 1988-05-13 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N019129-001 MAXZIDE 50MG;75MG TABLET / ORAL AB RLD, RS 1984-10-22 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N019129-003 MAXZIDE-25 25MG;37.5MG TABLET / ORAL AB RLD 1988-05-13 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N019129-001 MAXZIDE 50MG;75MG TABLET / ORAL AB RLD, RS 1984-10-22 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N019129-003 MAXZIDE-25 25MG;37.5MG TABLET / ORAL AB RLD 1988-05-13 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N019129-001 MAXZIDE 50MG;75MG TABLET / ORAL AB RLD, RS 1984-10-22 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N019129-003 MAXZIDE-25 25MG;37.5MG TABLET / ORAL AB RLD 1988-05-13 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N019129-001 MAXZIDE 50MG;75MG TABLET / ORAL AB RLD, RS 1984-10-22 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N019129-003 MAXZIDE-25 25MG;37.5MG TABLET / ORAL AB RLD 1988-05-13 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N019129-001 MAXZIDE 50MG;75MG TABLET / ORAL AB RLD, RS 1984-10-22 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N019129-003 MAXZIDE-25 25MG;37.5MG TABLET / ORAL AB RLD 1988-05-13 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N019129-001 MAXZIDE 50MG;75MG TABLET / ORAL AB RLD, RS 1984-10-22 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N019129-003 MAXZIDE-25 25MG;37.5MG TABLET / ORAL AB RLD 1988-05-13 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N019129-001 MAXZIDE 50MG;75MG TABLET / ORAL AB RLD, RS 1984-10-22 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N019129-003 MAXZIDE-25 25MG;37.5MG TABLET / ORAL AB RLD 1988-05-13 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N019129-001 MAXZIDE 50MG;75MG TABLET / ORAL AB RLD, RS 1984-10-22 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N019129-003 MAXZIDE-25 25MG;37.5MG TABLET / ORAL AB RLD 1988-05-13 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N019129-001 MAXZIDE 50MG;75MG TABLET / ORAL AB RLD, RS 1984-10-22 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N019129-003 MAXZIDE-25 25MG;37.5MG TABLET / ORAL AB RLD 1988-05-13 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N019129-001 MAXZIDE 50MG;75MG TABLET / ORAL AB RLD, RS 1984-10-22 8072bd15b7f6…2024-05-31 18:47 UTC 2024-05 N019129-003 MAXZIDE-25 25MG;37.5MG TABLET / ORAL AB RLD 1988-05-13 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N019129-001 MAXZIDE 50MG;75MG TABLET / ORAL AB RLD, RS 1984-10-22 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N019129-003 MAXZIDE-25 25MG;37.5MG TABLET / ORAL AB RLD 1988-05-13 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N019129-001 MAXZIDE 50MG;75MG TABLET / ORAL AB RLD, RS 1984-10-22 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 N019129-003 MAXZIDE-25 25MG;37.5MG TABLET / ORAL AB RLD 1988-05-13 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N019129-001 MAXZIDE 50MG;75MG TABLET / ORAL AB RLD, RS 1984-10-22 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 N019129-003 MAXZIDE-25 25MG;37.5MG TABLET / ORAL AB RLD 1988-05-13 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 N019129-001 MAXZIDE 50MG;75MG TABLET / ORAL AB RLD, RS 1984-10-22 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N019129-003 MAXZIDE-25 25MG;37.5MG TABLET / ORAL AB RLD 1988-05-13 74a2ff9319b5…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 3 · 86 observed states.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
FDA-Initiated Inactive NDC Indexing# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 63629-6404-1 63629640401 30 TABLET in 1 BOTTLE (63629-6404-1) 30 tablet 2015-09-17 0000-00-00 No No Current